Skip to main content
. 2021 Dec 23;9:808864. doi: 10.3389/fcell.2021.808864

FIGURE 2.

FIGURE 2

The free energy landscape of the first and second principal components (PC1 vs PC2) from MD simulations of the ALK–lorlatinib (A), ALKI1171N−F1174I–lorlatinib (B), ALK–gilteritinib (C), and ALKI1171N−F1174I–gilteritinib (D). The unit of free-energy values is kcal/mol.